Kelly McGrail-Pokuta joins Prime Therapeutics as vice president, pharmacy trade relations
McGrail-Pokuta brings to Prime more than 25 years of combined experience in the healthcare and pharmaceutical industries
August 13, 2019
McGrail-Pokuta will oversee the strategic direction and management of all pharmaceutical manufacturer relationships in support of Prime’s Total Drug Management business model.
McGrail-Pokuta brings to Prime more than 25 years of combined experience in the healthcare and pharmaceutical industries. She has held leadership positions within OptumRx and Diplomat Pharmacy, plus program and product management positions with then CVS Caremark and pharmaceutical companies. Most recently she worked as a consultant in the pharmacy benefit management and pharmacy space.
“Kelly is a seasoned expert in managing the broad continuum of pharmaceutical manufacturer relationships necessary to drive innovative and successful outcomes in a rapidly changing environment” said Jarrod Henshaw, senior vice president, chief supply chain and industry relations officer for Prime. “Her broad experience will help us deliver on our total drug management commitment to our plans and our members, and we are thrilled to have her leading our trade relations efforts.”
McGrail-Pokuta holds a Doctor of Pharmacy degree from the University of Illinois at Chicago and completed her clinical pharmacy practice residency at the University of Illinois Hospital and Clinics.
October 14, 2021
In first of its kind study, Prime Therapeutics explores paroxysmal nocturnal hemoglobinuria (PNH) C5 inhibitor treatment rates
EAGAN, Minn. – Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) used its…
October 6, 2021
Prime Therapeutics launches new MedsYourWay™ offering, now giving Blue Plan members home delivery prescription option using Amazon Pharmacy
EAGAN, Minn. – Prime Therapeutics LLC, a leading pharmacy benefit manager, announces its…
September 29, 2021
Prime Therapeutics and Pear Therapeutics announce first comprehensive value-based agreement for prescription digital therapeutics reSET® and reSET-O® for the treatment of substance and opioid use disorders
BOSTON and EAGAN, Minn. – More than 20 million Americans struggle with drug…